Saturday 17 October 2026
Export GCTK’s income statement to Excel — free account
GlucoTrack, Inc.
GCTK Healthcare Medical Instruments & Supplies
In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.
0.73
0.10
−12.05%
Follow GCTK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (620.63%) | (527.20%) | 381.20% | 4,068.29% |
+8 more TTM periods Free account |
|
| (272.48%) | (241.82%) | (281.60%) | (567.22%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
1,054.70% | 2,618.45% | (639.45%) | (875.52%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(48.55) | (149.58) | (370.43) | (247.98) | |
Free Cash Flow |
(16.22) | (16.35) | (15.34) | (14.88) | |
Capital Expenditures |
— | — | (0.10) | (0.08) | |
| Other line items | |||||
Cash ROIC |
(1,226.08%) | (246.22%) | (112.57%) | (107.21%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.02 | 0.97 | 0.79 | 0.57 | |
Depreciation/Fixed assets |
5.69 | 3.30 | 1.62 | (1.75) | |
Capex/Depreciation |
0.00 | 0.00 | (0.43) | 0.30 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(48.55) | (149.58) | (368.12) | (246.72) | |
Capex per Share |
0.00 | 0.00 | (2.32) | (1.27) | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates